Skip to content

Pharmacy

ISSN 2226-4787

3 papers in the library · 8 citations · publishing 2021-2025

Papers

Sort Most recent Most cited

Lysergic Acid Amide (LSA), an LSD Analog: Systematic Review of Pharmacological Effects, Adverse Outcomes, and Therapeutic Potentials.

Pharmacy July 21, 2025 Paula S C C Castro, Kae Leopoldo, Maria Olivia Pozzolo Pedro et al. 2 citations

Objective: To systematically review the scientific literature on lysergic acid amide (LSA), focusing on its physical, neurobiological, and social effects, as well as its potential risks and therapeutic uses. Methods: A systematic review was conducted across PubMed, Google Scholar, and Web of Science up to December 2023, using keywords such as "ergine," "lysergic acid amide," and "legal high."...

DOI: 10.3390/pharmacy13040098 (opens in new tab) Full text (opens in new tab) Anxiety Cluster headaches Legal highs Psychotropic substances +15

Mindfulness-Based Stress Reduction (MBSR) for Chronic Pain Management in the Community Pharmacy Setting: A Cross-Sectional Survey of the General Public's Knowledge and Perceptions.

Pharmacy September 21, 2023 Klaudia Harris, Jazmyne Jackson, Holly Webster et al. 4 citations

Patient access to mindfulness-based stress reduction (MBSR), a complementary and integrative health approach that is proven to reduce chronic pain, can be increased via community pharmacy-based implementation. However, the general public's awareness and preferences regarding MBSR as a treatment option for chronic pain, including provider roles (pharmacist vs. non-pharmacist), are unclear....

DOI: 10.3390/pharmacy11050150 (opens in new tab) Full text (opens in new tab) Chronic pain Community pharmacy Pharmacy expanded scope Pharmacy roles

Role of the Pharmacist in Managing Treatment-Resistant Depression: A Focus on Ketamine

Pharmacy June 25, 2021 Linda Xing Yu Liu, Marina Golts, Virginia Fernandes 2 citations

The impact of depression is well described in the literature, and it is most prominent in patients who have trialed multiple treatments. Treatment-resistant depression (TRD) is particularly debilitating, and it is associated with significant morbidity and mortality. Despite this, there seems to be therapeutic inertia in adopting novel therapies in current practice. Ketamine is an...